CV Sciences (CVSI) EBIAT (2016 - 2025)
CV Sciences (CVSI) has disclosed EBIAT for 14 consecutive years, with -$206000.0 as the latest value for Q4 2025.
- Quarterly EBIAT rose 71.63% to -$206000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$958000.0 through Dec 2025, up 59.98% year-over-year, with the annual reading at -$958000.0 for FY2025, 59.98% up from the prior year.
- EBIAT hit -$206000.0 in Q4 2025 for CV Sciences, up from -$382000.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of $5.7 million in Q1 2023 to a low of -$8.9 million in Q4 2021.
- Historically, EBIAT has averaged -$1.2 million across 5 years, with a median of -$677000.0 in 2024.
- Biggest five-year swings in EBIAT: tumbled 2477.5% in 2022 and later skyrocketed 357.37% in 2023.
- Year by year, EBIAT stood at -$8.9 million in 2021, then surged by 73.89% to -$2.3 million in 2022, then surged by 62.43% to -$869000.0 in 2023, then increased by 16.46% to -$726000.0 in 2024, then skyrocketed by 71.63% to -$206000.0 in 2025.
- Business Quant data shows EBIAT for CVSI at -$206000.0 in Q4 2025, -$382000.0 in Q3 2025, and -$261000.0 in Q2 2025.